baber/WOPTO huggingface dataset:
Patent NZ-331971-A (NZ)
Title: Slot machine game with roaming wild card
Inventor: BENNETT NICHOLAS LUKE
IPC: G07F17/34
Filed: 1997-02-28
Abstract: A gaming machine 40 having display means and game control means arranged to control images displayed on the display means is claimed.  The game control means is arranged to play a game wherein a plurality of symbols 43 are randomly selected and displayed on the display means and, if a winning combination results, the machine awards a prize.  Upon occurrence of a predetermined triggering event, a wild card symbol is displayed in a first display location and then progressively moved to each of a predetermined number of other display locations.  A prize is awarded for winning combinations formed with the wild card symbol for each location in which the wild card symbol is displayed.  The display means may comprise a video display simulating a set of rotatable reels 42, each carrying a plurality of symbols.  The video display may display cards selected from a standard 52 or 53 card deck. The wild card symbol may be a penguin moved from one location to another via an animated walking motion.
Patent NZ-332043-A (NZ)
Title: Washing machine clutch control, retries in case of failure to disengage
Inventor: OKAZAKI KIYOSHI
IPC: D06F37/30
Filed: 1998-09-24
Abstract: The tub and agitator of a washing machine are coupled by a clutch 36.  This clutch is movable between a first position as shown where it couples the agitator and tub to the motor, and a second position where the tub is decoupled from the motor and held fixed.  The clutch, which rotates with agitator shaft 18, is moved between the two positions by a cam surface 59 which is moved into the path of the clutch as the motor rotates slowly.  A clutch position detector, such as magnet 50 and reed switch 52, detects whether the clutch is in the second position.  If the washing machine controller has commanded the clutch to move to the second position after a spin cycle, and the position detector detects that it has not moved, then water is added to the tub.  This is to dislodge any laundry that might have jammed between the agitator and tub.  The controller then re-tries to move the clutch by slowly rotating the motor.  If the clutch still does not move to the second position, the wash cycle is stopped, and an alarm sounds.
Patent NZ-334316-A (NZ)
Title: Readily removable labels having perforations at ends to allow adhesive penetration
Inventor: OTRUBA SVATOBOJ
IPC: G02B1/10
Filed: 1997-09-03
Abstract: A label (25) to be wrapped around and adhered to a container (35) by adhesive in the vicinity of its ends, and which is perforated in the vicinity of its ends to allow access of solvent to dissolve or loosen the adhesive and facilitate removal of the label (25); also a method of so labeling a container (35) so labeled.
Patent NZ-334319-A (NZ)
Title: Nutritional formula for phenylketonuria patients comprising a mixture of caesino-glyco-macropeptide and complementary essential amino acids other than Phe
Inventor: MASSON GERARD
IPC: A23L33/175
Filed: 1997-08-25
Abstract: A nutritional formula for PKU patients. The nutritional formula has, as a protein source, a mixture of caseino-glyco-macropeptide and complementary essential amino acids other than Phe to provide a balanced amino acid profile. Vitamins and minerals sufficient to meet daily requirements are also included. When used as a complete diet, the nutritional formula includes a carbohydrate source and a fat source. However the nutritional formula may also be used as a protein supplement in which case the carbohydrate source and the fat source may be omitted. The nutritional formula has a pleasant taste. Further claimed is the nutritional formula in a powdered from and a method for administering the formula to a PKU patient.
Patent NZ-335201-A (NZ)
Title: Molten steel transfer element and its manufacturing
Inventor: DUBOIS PASCAL
IPC: B22D41/52
Filed: 1997-10-22
Abstract: PCT No. PCT/EP97/05822 Sec. 371 Date Jun. 7, 1999 Sec. 102(e) Date Jun. 7, 1999 PCT Filed Oct. 22, 1997 PCT Pub. No. WO98/17422 PCT Pub. Date Apr. 30, 1998The invention concerns a transfer element for transferring molten steel between an upstream container such as a tundish and a downstream vessel such as a continuous casting mold. this element is comprised of a body (4) that delimits a steel entrance zone, a channel (6) and a steel exit zone (9). It has at least one divider (16) in its exit zone (9) for dividing the steel flux into at least two jets. The divider is comprised of two parts of complementary form (19) solid with the body (4), located opposite each other and separated by an interstice (18).
Patent NZ-337646-A (NZ)
Title: Use of chimaeric gene to generate highly specific targeting effects as a mode to determine a targeted resistance to disease-causing agents in plants by causing specific cell disruption at a second gene site
Inventor: O'REILLY DAVID
IPC: C12N15/09
Filed: 1998-03-27
Abstract: A chimaeric gene which comprises a promoter which expresses in more than one region of the organism to be affected. The promoter is linked to an agent which affects the functioning of an endogenous gene in the plant which is also expressed in more than one region of the plant. The promoter and agent are selected so that there is an overlap in their expression sites at one or more desired locations. This overlap site(s) gives increased specificity and targeting of gene expression.
Patent NZ-501879-A (NZ)
Title: Device for a materials handling vehicle with actuator at entrance of compartment with alert signal generated when a portion of an operator's body engages the actuator
Inventor: DUNLAP DANNY L
IPC: B66F17/00
Filed: 1998-07-14
Abstract: A materials handling vehicle is provided with a frame including an operator's compartment (15) having an entrance (30), a drive mechanism (not shown) supported on the frame, a material handling unit coupled to the frame, and a device (24) including an actuator (45) located across the threshold of the entrance (30) of the operator's compartment (15). The device (24) generates an alert signal when a portion of an operator's body (30) engages the actuator.
Patent NZ-503664-A (NZ)
Title: A method for purifying an RNA virus comprising generating a clonal virus and purifying the clonal virus by ultracentrifugation without pelleting
Inventor: ROBERTS MICHAEL S
IPC: A61K35/76
Filed: 1998-10-09
Abstract: Method of purifying and using such viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response. The use in treating neoplastic disease including cancer and large tumours are also described. RNA and DNA viruses are useful in this regard. The method describes a method of purifying an RNA by initially plaque purifying to generate a clonal virus, inoculating eggs with the clonal virus, incubating the eggs, chilling the eggs, harvesting allantoic fluid from the eggs, removing cell debris from the allantoic fluid prior to the ultracentrafugation step.
Patent NZ-505807-A (NZ)
Title: Controlled release oral dosage form containing [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride; useful for the treatment or prophylaxis of dementia
Inventor: GLINECKE ROBERT
IPC: A61K9/30
Filed: 1999-03-05
Abstract: [R-(Z)]-a(methoxyimino)-a-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochloride enhances acetylocholine function via an action at muscarinic receptors within the central nervous system, and thus is useful in the treatment of dementia.  Due to said compound having high water solubility and being active at low dosages it is often inconvenient for dosage administration purposes.  Disclosed is a controlled release oral dosage form containing said compound, ethylcellulose, dibasic calcium phosphate dihydrate, microcrystalline cellulose, compressed into tablets.  Said tablet is coated with a solution consisting of hydroxymethylcellulose followed by a coating of ethylcellulose aqueous dispersion with oleic acid, ammonium hydroxide and plasticizer.
Patent NZ-513927-A (NZ)
Title: Lumbar support
Inventor: FOOTITT IAN COLIN
IPC: A47C1/032
Filed: 2001-09-03
Abstract: A back portion for a chair 10 has a peripheral frame defining an opening therein. A lumbar support portion 36 is disposed in the opening. The lumbar support portion 36 includes a rigid panel 207. Two hinge devices 214 are hingedly mounted on opposite sides of the peripheral frame 34. The lumbar support portion 207 is mounted on the peripheral frame by the two hinge devices 214. Each hinge device 214 has a biasing device (not shown) associated with it to bias the hinge devices 214 forwardly relative to the peripheral frame. Various optional features are disclosed.
Patent NZ-513982-A (NZ)
Title: Article carrier and blank therefor
Inventor: BAKX MARTINUS C M
IPC: B65D1/00
Filed: 2000-03-06
Abstract: An article carrier and a blank (10) for forming an article carrier of the basket type comprising in sequence a first end panel (14), a first side panel (16), a second end panel (18), a second side panel (20) and a third end panel (22) foldably connected together one to next. A base panel (72, 74) is hinged to respective one of the side panels (16, 20) and a handle a structure comprising first and second handle panels (38 and 52) is foldably connected to one or more of medial support panels (12 and 24) or end panels. The first and second handle panels (38 and 52) are adjacent to the first and second side panels (16 and 20) respectively and are separated therefrom. The first and second handle panels are so constructed and arranged to be placed in face contacting relationship to form a two ply handle when the carrier is set up. There further comprises a blank (80, 80a) for forming an internal partition structure which blank comprises a medial panel (86, 86a) adapted to be connected to the handle structure and to at least one of the end panels and a plurality of transverse partition panels (82/82a, 84/84a) struck from the medial panel to create a plurality of article receiving cells on one side of the handle panel when the carrier is formed from the blank.
Patent NZ-515229-A (NZ)
Title: Process for separating olefins from saturated hydrocarbons
Inventor: FENOUIL LAURENT ALAIN
IPC: C07C1/04
Filed: 2000-05-09
Abstract: Process for separating and isolating olefins from saturated hydrocarbons, and in particular, to a process for separating and isolating olefins from saturated hydrocarbons in a Fisher-Tropsch stream. There is provided a process for separating olefins from saturated hydrocarbons in a feedstock, comprising: contacting a feedstock comprising olefins and saturated hydrocarbons, such as paraffins, with a linear polyaromatic compound under conditions effective to form a reaction mixture comprising linear polyaromatic compound-olefin adducts and saturated hydrocarbons; separating the linear polyaromatic compound-olefin adducts from the saturated hydrocarbons in the reaction mixture to form a saturated hydrocarbon stream and an adducted olefin stream; dissociating the linear polyaromatic compound-olefin adducts to form linear polyaromatic compounds and an olefin composition; and optionally separating the linear polyaromatic compound formed in step c) from the olefin composition; whereby the olefin composition is enriched in the concentration of olefins over the concentration of olefins in the feedstock and the saturated hydrocarbon stream is enriched in saturated hydrocarbons over the concentration of saturated hydrocarbons in the feedstock.
Patent NZ-516853-A (NZ)
Title: Oxazolidinones and their use as anti-infectives
Inventor: GORDEEV MIKHAIL F
IPC: C07D417/10
Filed: 2000-07-26
Abstract: Compounds of formula (I) that are useful in treating or preventing an infectious disorder in a human or other animal subject are disclosed, wherein: R6 is thioacyl, alkoxycarbonyl, aminothiocarbonyl, alkoxythiocarbonyl, alkylthio(carbonyl), or alkylthio(thiocarbonyl); R7 is aryl or monocyclic heteroaryl; and R8-R9 are as defined in the specification; provided that when R7 is aryl , R6 is different from alkylthio(carbonyl).
Patent NZ-517898-A (NZ)
Title: Flexible illuminators for phototherapy
Inventor: RUSSELL THOMAS A
IPC: A61N5/06
Filed: 2000-08-18
Abstract: Flexible illuminators for external phototherapy are disclosed each having at least one light generating source, preferably a plurality of light-generating sources, on a flexible substrate. The flexible substrate may be a circuit board, and the light-generating source may be surface mount LEDs. Structures for diffusing light emitted from the discrete light-generating sources and/or for transferring heat away from a skin contact surface are provided. The illuminators may be formed so as to be wrapped around an infant or a limb of an adult, or may be provided in larger configurations, such as a mat. The illuminators may be passively or actively cooled so that the skin contact surface remains below a desired temperature
Patent NZ-518033-A (NZ)
Title: Delayed release/slow release drugs lacking enteric coat
Inventor: MUIR IAN STUART
IPC: A61K9/20
Filed: 2000-09-29
Abstract: A solid dose unit for the delayed release of a drug comprising: a) a core comprising the drug and at least one disintegrant, and b) an outer semi-permeable membrane surrounding the core which comprises a permeable water insoluble polymer and at least 50% by weight glidant, and lacks an enteric coating. Examples of the solid dose unit may use lansoprazole as an active drug.
Patent NZ-521287-A (NZ)
Title: Method for sterilizing endoscopes
Inventor: FOURNIER STEPHANE
IPC: A61B1/12
Filed: 2001-02-09
Abstract: A method of sterilizing a hollow endoscope having a conduit is disclosed. An end of the endoscope conduit is connected to a sealed vessel such that the endoscope conduit is in fluid communication with the sealed vessel. The endoscope is placed in a sterilisation chamber and the chamber sealed. The sterilisation chamber is run through sterilisation cycles in which the pressure within the chamber is varied. During the pressure variation within the sterilising chamber, sterilising gas, i.e. ozone is drawn from the sterilising chamber via the endoscope conduit into the vessel. During the pressure variation the inner surface of the endoscope is subjected to sterilising conditions in addition to the outer surface of the endoscope.
Patent NZ-523172-A (NZ)
Title: Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
Inventor: MONNERET CLAUDE
IPC: A61K31/365
Filed: 2001-06-19
Abstract: The application discloses compound I wherein; R1 represents a group selected from hydrogen, linear or branched (C1-C6)-alkyl, aryl, aryl-(C1-C6) alkyl in which the alkyl moiety may be linear or branched, heteroaryl, heteroaryl-(C1-C6)alkyl in which the alkyl moiety may be linear or branched, linear or branched (C1-C6) alkylcarbonyl, aryloxycarbonyl, aryl-(C1-C6)alkoxycarbonyl in which the alkoxy moiety may be linear or branched, heterocycloalkylcarbonyl, linear or branched (C1-C6)alkylsulfonyl; arylsulfonyl, aryl-(C1-C6)alkylsulfonyl in which the alkyl moiety may be linear or branched and phosphonic, R2 represents an oxygen atom or a sulfur atom R3 represents a hydrogen atom a linear or branched (C1-C6)alkyl group, a cycloalkyl group or an aryl-(C1-C6) alkyl group in which the alkyl moiety may be linear or branched. X represents a group selected from Amino optionally substituted by one or two identical or different groups selected from linear or branched (C1-C6) alkyl,aryl and aryl(C1-C6) alkyl in which the alkyl moiety may be linear or branched A group of formula -N(R3)-X1-OR5 wherein R3 is defined herein as before, X1 represents a linear or branched (C1-C6)alkylene group and R5 represents a group selected from hydrogen, linear or branched (C1-C6)alkyl aryl and aryl-(C1-C6)alkyl in which the alkyl moiety may be linear or branched A group of formula -N(R3)-X1-NR6R7 wherein R3 and X1 are defined as hereinbefore and R6 and R7 which may be identical or different each represent s a group selected from hydrogen, linear or branched (C1-C6)alkyl, aryl and aryl-(C1-C6)alkyl in which he alkyl moiety may be linear or branched Hydroxy Linear or branched (C1-C6)alkoxy Aryloxy A group of formula -O-X1-OR5 wherein R5 and X1 are as defined hereinbefore And a group of formula -O-X1NR6R7 wherein R6 and R7 and X1 are as defined hereinbefore The isomers and addition salts thereof with pharmaceutically acceptable acid or base The process for the preparation of these compounds is also disclosed Pharmaceutical compositions containing the formula for the use in the treatment of cancers also disclosed.
Patent NZ-528098-A (NZ)
Title: Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
Inventor: SHUDO JUTARO
IPC: A61P37/08
Filed: 2002-02-22
Abstract: A topical patch preparation of a delayed-type hypersensitivity inducer such as 1-chloro-2,4-dinitrobenzene (DNCB), said preparation comprising: a cross-linked adhesive gel composition comprising a metallic aluminum cross linking agent and a delayed-type hypersensitivity inducer; and a support. The topical patch is suitable for use in the treatment of an immunocompromising disease
Patent NZ-530017-A (NZ)
Title: Conversation skills testing system
Inventor: SUDO SATORU
IPC: H04N7/14
Filed: 2001-06-13
Abstract: A conversation power testing system decides the conversation power of a student: by connecting a first testing video telephone terminal (11) and a student's video telephone terminal (26) through a network (25) to read a testing image from an image/voice storage device (23) and transmit it to the student's video telephone terminal (26); and by displaying the testing image on the display screen of the student's video telephone terminal (26), so that the conversation power of the student is decided on the basis of a talk of the student on the contents of the testing image or the conversations between the examiner and the student. Therefore, the test of the conversation power can be easily made even for a student at a remote place and at any time.
Patent NZ-530702-A (NZ)
Title: Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
Inventor: SCHOELKENS BERNWARD
IPC: A61K31/55
Filed: 2004-01-20
Abstract: Describes the use of an angiotensin II antagonist or a pharmaceutically acceptable salt thereof, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin in the manufacture of a medicament for the prevention or reduction of the risk of a cardiovascular event in a patient with an increased cardiovascular risk and no evidence of left ventricular dysfunction or heart failure where the cardiovascular event is stroke, cardiovascular death or myocardial infarction. (62) Divided out of 517468
Patent NZ-533226-A (NZ)
Title: Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
Inventor: GERMERAAD WILFRED THOMAS VINCE
IPC: C07K16/28
Filed: 2002-11-29
Abstract: A conjugate for targeting antigen presenting cells comprises at least one antigenic moiety conjugated to a targeting moiety that is capable of binding to a cell surface structure of an antigen presenting cell and that upon binding to an antigen presenting cell induces a CTL response and a T-helper response. The targeting moiety is capable of binding CD33+ CD14- dendritic cell and CD33dim CD16- dendritic cells and is essentially incapable of binding CD3+ T cells and CD56+ NK cells. Preferably the targeting moiety is an IgG4 immunoglobin. Pharmaceutical compositions comprising the conjugate or comprising antigen presenting cells contacted with the conjugate are useful for vaccinations, as an anti-parasitic, anti-fungal, anti-bacterial, anti-viral or anti-tumor agent, and for the prevention and treatment of diseases such as Alzheimer's , atherosclerosis, cancer diabetes, AIDS, and hepatitis.
Patent NZ-534227-A (NZ)
Title: Guillotine valve
Inventor: SANTIAGO OSVALDO RODRIGUES
IPC: F16J15/46
Filed: 2003-01-10
Abstract: A guillotine valve comprises a single block body 1 incorporating on each one of its faces, downstream or upstream in relation to the flow direction of fluid passing through the valve, two sealing elements 7, mounted fully opposed and in mutual contact. The sealing elements 7, also called hose sections, are manufactured from elastomeric material and are interchangeable. The hose sections 7 are hollow in construction, and each one is provided with an airtight pneumatic circumferential chamber 8, filled with air.
Patent NZ-536123-A (NZ)
Title: Nucleoside derivatives for treating hepatitis C virus infection
Inventor: ROBERTS CHRISTOPHER DON
IPC: C07H19/06
Filed: 2003-05-06
Abstract: A compound of the formula Ia is described, as well as its use for the treatment of hepatitis C virus in a mammal. R and R1 are independently selected from the group consisting of: hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, and substituted alkynyl - provided that R and R1 are not both hydrogen; R2 is selected from the group consisting of: cycloalkyl, substituted cycloalkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, acylamino, guanidino, amidino, thioacylamino, aryl, substituted aryl, heteroaryl, substituted heteroaryl, -NR3R4 where R3 and R4 are joined to form, together with the nitrogen atom bond thereto, a heterocyclic, substituted heterocyclic, heteroaryl, or substituted heteroaryl; or -NR5NR3R4; W is selected from the group consisting of: hydrogen, phosphate, phosphonate, acyl, alkyl, sulfonate ester, a lipid, an amino acid, a carbohydrate, a peptide, and cholesterol; Y is selected from the group consisting of: hydrogen, halo, hydroxy, alkylthio, -NR3R4; Z is selected from the group consisting of: hydrogen, halo, hydroxy, alkyl, azido, -NR3R4, and -NR5NR3R4. A process of preparing a compound of Formula Ia is described to comprise coupling an optionally protected sugar to a purine base; or coupling an organometallic carbon nucleophile with a ketone which has been produced by oxidising an optionally protected nucleoside.
Patent NZ-536832-A (NZ)
Title: The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
Inventor: HOLMES DAVID GRENVILLE
IPC: C07D207/16
Filed: 2003-06-02
Abstract: Disclosed is the use of compounds of formula (IA) or (IB) for the manufacture of medicaments for modulating hyperlipidemia and/or conditions associated with hyperlipidemia, wherein: R' is hydroxy, alkoxy, alkanoyloxy or R5R4N-CO-O-, and R" is H, or R' and R" are independently alkyl.
Patent NZ-541862-A (NZ)
Title: Use of palonosetron for treating post-operative nausea and vomiting
Inventor: BARONI LUIGI
IPC: A61P1/08
Filed: 2004-02-18
Abstract: Disclosed is a unit dosage of from 0.025 to 0.250 mg of palonosetron hydrochloride for the treatment or prevention of post-operative nausea and vomiting (PONV), wherein: said palonosetron hydrochloride is present at a concentration ranging from 0.03 to 0.2 mg/ml or wherein said medicament dose has a pH of from 4.0 to 6.0 or said medicament dose further comprises trisodium citrate, mannitol or EDTA.